In our previous studies in mouse system, we have demonstrated that protective effect of IRT5 probiotics in IBD and AD is associated with generation of regulatory DCs (rDCs), which in turn promoted the generation of CD4+Foxp3+ T cells. The gene discussed is CD4; the disease is inflammatory bowel disease.